On May 8, 2025, Accelerate Diagnostics, Inc. filed for Chapter 11 bankruptcy, seeking to continue operations while pursuing a sale of its assets valued at approximately $36.9 million to Indaba Capital Management. The company has also secured a $12.5 million postpetition loan to support ongoing activities during the bankruptcy process.